To our knowledge, this is the first successful demonstration in which automated, unbiased deep learning–based phenotypic profiling is able to discriminate between primary cells from PD patients (both sporadic and LRRK2) and healthy controls (Fig. 5b, c, d). This evidence concerns the gene LRRK2 and Parkinson disease.